161 related articles for article (PubMed ID: 36183437)
41. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
[TBL] [Abstract][Full Text] [Related]
42. Skullcapflavone I suppresses proliferation of human lung cancer cells via down-regulating microRNA-21.
Yang Y; An R; Feng T; Qin X; Zhang J; Bo Y; Niu B
Exp Mol Pathol; 2019 Oct; 110():104285. PubMed ID: 31301304
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.
Jiang DS; Wang YW; Jiang J; Li SM; Liang SZ; Fang HY
Int J Mol Med; 2014 Jul; 34(1):307-12. PubMed ID: 24788552
[TBL] [Abstract][Full Text] [Related]
44. Circular RNA circ-PLCD1 functions as a tumor suppressor in non-small cell lung cancer by inactivation of PI3K/AKT signaling pathway.
Si J; Jin J; Sai J; Liu X; Luo X; Fu Z; Wang J
Hum Cell; 2022 May; 35(3):924-935. PubMed ID: 35301686
[TBL] [Abstract][Full Text] [Related]
45. Tetrahydrocurcumin‑induced autophagy via suppression of PI3K/Akt/mTOR in non‑small cell lung carcinoma cells.
Song G; Lu H; Chen F; Wang Y; Fan W; Shao W; Lu H; Lin B
Mol Med Rep; 2018 Apr; 17(4):5964-5969. PubMed ID: 29436654
[TBL] [Abstract][Full Text] [Related]
46. Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells.
Guerriero I; D'Angelo D; Pallante P; Santos M; Scrima M; Malanga D; De Marco C; Ravo M; Weisz A; Laudanna C; Ceccarelli M; Falco G; Rizzuto A; Viglietto G
Oncotarget; 2017 Mar; 8(12):19172-19191. PubMed ID: 27880728
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway.
Zhu Q; Liang X; Dai J; Guan X
Int J Clin Exp Pathol; 2015; 8(8):9175-81. PubMed ID: 26464663
[TBL] [Abstract][Full Text] [Related]
48. An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer.
Zhang J; Qu Z; Yao H; Sun L; Harata-Lee Y; Cui J; Aung TN; Liu X; You R; Wang W; Hai L; Adelson DL; Lin L
Biomed Pharmacother; 2019 Oct; 118():109169. PubMed ID: 31310954
[TBL] [Abstract][Full Text] [Related]
49. MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.
Xu S; Ge J; Zhang Z; Zhou W
Biomed Pharmacother; 2017 Dec; 96():634-641. PubMed ID: 29035829
[TBL] [Abstract][Full Text] [Related]
50. Luteoloside induces G
Zhou M; Shen S; Zhao X; Gong X
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
[TBL] [Abstract][Full Text] [Related]
51. Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC).
Tan AC
Thorac Cancer; 2020 Mar; 11(3):511-518. PubMed ID: 31989769
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway.
Ma M; Wang X; Chen X; Cai R; Chen F; Dong W; Yang G; Pang W
RNA Biol; 2017 Mar; 14(3):347-360. PubMed ID: 28085550
[TBL] [Abstract][Full Text] [Related]
53. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer.
Yu L; Wei J; Liu P
Semin Cancer Biol; 2022 Oct; 85():69-94. PubMed ID: 34175443
[TBL] [Abstract][Full Text] [Related]
54. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway.
Ma Z; Qi J; Meng S; Wen B; Zhang J
Eur J Appl Physiol; 2013 Oct; 113(10):2473-86. PubMed ID: 23812090
[TBL] [Abstract][Full Text] [Related]
55. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Zhao L; Zhang J; Fan Y; Li Y
Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173
[TBL] [Abstract][Full Text] [Related]
56. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway.
Yiyan S; Yang S; Li D; Li W
Curr Cancer Drug Targets; 2022; 22(1):86-95. PubMed ID: 34325639
[TBL] [Abstract][Full Text] [Related]
58. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer.
Xie FW; Liu JC
Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487
[TBL] [Abstract][Full Text] [Related]
59. MicroRNAs and the PTEN/PI3K/Akt pathway in gastric cancer (Review).
Hu M; Zhu S; Xiong S; Xue X; Zhou X
Oncol Rep; 2019 Mar; 41(3):1439-1454. PubMed ID: 30628706
[TBL] [Abstract][Full Text] [Related]
60. PI3K/Akt/mTOR Pathways Inhibitors with Potential Prospects in Non-Small-Cell Lung Cancer.
Alharbi KS; Shaikh MAJ; Almalki WH; Kazmi I; Al-Abbasi FA; Alzarea SI; Imam SS; Alshehri S; Ghoneim MM; Singh SK; Chellappan DK; Oliver BG; Dua K; Gupta G
J Environ Pathol Toxicol Oncol; 2022; 41(4):85-102. PubMed ID: 36374963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
